INOVIO to Report Fourth Quarter and Year-End 2022 Financial Results on March 1, 2023

Rhea-AI Summary

INOVIO (NASDAQ: INO) announced that it will release its fourth quarter and year-end 2022 financial results on March 1, 2023, after market close. A conference call and webcast will follow at 4:30 p.m. ET to discuss the results and provide a business update. The company is focused on developing DNA medicines for HPV-associated diseases and cancer, utilizing its proprietary CELLECTRA® device. Details for accessing the live event and archived presentation are available on their investor relations website.

PLYMOUTH MEETING, Pa., Feb. 15, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that fourth quarter 2022 financial results will be released after the market close on March 1, 2023. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.

A live and archived version of the audio presentation will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts.

About INOVIO

INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases. INOVIO's DNA medicines in development are delivered using its investigational proprietary smart device, CELLECTRA^®, to produce immune responses against targeted pathogens and cancers. For more information, visit www.inovio.com.

Contacts

Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

View original content:https://www.prnewswire.com/news-releases/inovio-to-report-fourth-quarter-and-year-end-2022-financial-results-on-march-1-2023-301747225.html

SOURCE INOVIO Pharmaceuticals, Inc.

FAQ

When will INOVIO release its fourth quarter financial results?

INOVIO will release its fourth quarter 2022 financial results on March 1, 2023, after market close.

What time is INOVIO's conference call on March 1, 2023?

The conference call will take place at 4:30 p.m. ET on March 1, 2023.

How can I access the presentation and Q&A for INOVIO's financial results?

The presentation will be available online on INOVIO's investor relations website, and it will include a live Q&A session with analysts.

What is INOVIO focused on developing?

INOVIO is focused on developing DNA medicines to treat HPV-associated diseases, cancer, and infectious diseases.